false
OasisLMS
Catalog
SCCM Resource Library
NEBulous Use of Bronchodilators
NEBulous Use of Bronchodilators
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In this talk, the speaker discusses the continuous use of albuterol in mechanically ventilated patients and the lack of evidence supporting its effectiveness. They review the historical use of aerosolized bronchodilators, particularly albuterol, and how it has become a standard of care for intubated patients with asthma or COPD. However, the routine use of albuterol in patients with acute respiratory distress syndrome (ARDS) or hypoxic respiratory failure has no basis in fact and has been shown to have no significant impact on outcomes. The speaker emphasizes that albuterol should only be used in patients with asthma or COPD exacerbation, not in ventilated patients in the medical ICU. They also discuss the challenges in delivering aerosolized bronchodilators to mechanically ventilated patients and the need for better monitoring of its effectiveness. The speaker concludes by advocating for the reduction of unnecessary aerosol therapy in ventilated patients, both for the financial benefit and the avoidance of potential complications.
Asset Subtitle
Pulmonary, Pharmacology, 2023
Asset Caption
Type: two-hour concurrent | Treatments on Autopilot (SessionID 1119558)
Meta Tag
Content Type
Presentation
Knowledge Area
Pulmonary
Knowledge Area
Pharmacology
Membership Level
Professional
Membership Level
Select
Tag
Pulmonary
Tag
Pharmacology
Year
2023
Keywords
albuterol
mechanically ventilated patients
effectiveness
aerosolized bronchodilators
asthma
×
Please select your language
1
English